Table of Contents:
I. Adolescent Brain Cognitive Development Funding Opportunity Announcement
II. CPDD preconference grant writing workshop in Phoenix, Arizona on Friday, June 12, 2015
III. Big Data to Knowledge (BD2K) Funding Opportunities
IV. New BRAIN Initiative Funding Opportunities
V. RFA-DA-15-018 Developing Technologies and Tools to Monitor HIV Reservoirs and How they May be Altered by Exposure to Substance of Abuse (R21/R33)
VI. 17th Annual NIH SBIR/STTR; Conference October 27 – 29, 2015; Seattle, Washington
I. Adolescent Brain Cognitive Development Funding Opportunity Announcement
The goal of the Adolescent Brain Cognitive Development project is to establish a national, multisite, longitudinal cohort study to prospectively examine the neurodevelopmental and behavioral effects of substance use from early adolescence (approximately age 9-10) through the period of risk for substance use and substance use disorders. Additional information about the ABCD project can be found on the Collaborative Research on Addiction at NIH (CRAN) website at: http://addictionresearch.nih.gov/.
We look forward to hearing from you.
Please see the links below and note that the due date for applications is April 14, 2015.
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-014.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-015.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-016.html
II. CPDD preconference grant writing workshop in Phoenix, Arizona on Friday, June 12, 2015
CPDD preconference grant writing workshop in Phoenix, Arizona on Friday, June 12, 2015 for early stage investigators (postdoc-junior faculty) as part of the NIDA Diversity Scholars Network (NDSN) program. The NDSN is a rigorous and comprehensive mentorship program aimed at improving the funding of outstanding underrepresented early stage minority investigators in substance abuse research.
This meeting will provide scholars with information on NIDA's research funding priorities, grant development and review, research grant mechanisms, funding opportunity announcements, grant application/submission process, review and research/career tips. Early stage investigators should be less than 10 years since receipt of their terminal degree or less than five years in the field of addictions research if the terminal degree was awarded more than 10 years ago. In addition, applicants should be adequately positioned to submit an NIH research grant (i.e. R03, R21, R01) or Mentored Career Development Award (K) application within a year of the program date.
Interested applicants should email Albert Avila (aavila@nida.nih.gov) the following application materials in Word format as an email attachment by March 1, 2015:
· E-mail subject line: CPDD 2015 NIDA Diversity Scholar Network Program
· Attach a cover letter stating eligibility, interest in the program, description of research experience as they relate to substance abuse and addiction research, long-term professional research goals
· Attach a detailed 2-3 page description of the proposed research concept for a future grant application; research concepts must be directly relevant to the NIDA mission and research goals (selectees may be required to submit a more detailed research proposal prior to the workshop)
· Attach a recent curriculum vitae (list all NIH grant support if applicable)
· Please include a current email and telephone number
The announcement contains program details, eligibility, and application information. Feel free to contact Albert Avila at aavila@nida.nih.gov with questions.
III. Big Data to Knowledge (BD2K) Funding Opportunities
Funding opportunities are available through NIH Big Data to Knowledge (BD2K) Initiative in the areas of Enhancing Training, and Analysis Methods and Software.
For further information on BD2K and related funding opportunities see: www.bd2k.nih.gov
IV. New BRAIN Initiative Funding Opportunities
Funding opportunities are available through Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative in the areas of large scale recording, novel approaches to understanding the nervous system and training in computational methods. For further information on BRAIN and related
funding opportunities see: http://braininitiative.nih.gov/funding.htm
V. RFA-DA-15-018 Developing Technologies and Tools to Monitor HIV Reservoirs and How they May be Altered by Exposure to Substance of Abuse (R21/R33)
This R21/R33 FOA is designed to support research that will advance the goals of detecting and quantifying latent viral reservoirs in the brain, and whether substances of abuse can alter the latent viral reservoirs. The objective of this FOA is to support projects developing technologies and tools to detect, quantify, and characterize HIV brain reservoirs, including HIV within macrophage/microglia, astrocytes, or within specific brain regions, and how these reservoirs may be altered by exposure to substances of abuse. The ability to monitor and quantify latent HIV in living human brains is one of the ultimate goals of supporting this work. It is, therefore, necessary to either improve our ability to detect and quantify HIV latent reservoirs in living human brain, and/or examine potential biomarkers of latent infection in the brain to determine if substances of abuse modulate the characteristics of the reservoirs. This initiative should help to establish important groundwork for the detection and eradication of HIV brain reservoirs in substance-abusing populations.
VI. 17th Annual NIH SBIR/STTR; Conference October 27 – 29, 2015; Seattle, Washington
The 17th Annual NIH SBIR/STTR Conference will be held on Tuesday, October 27 – Thursday, October 29, 2015, in Seattle, Washington. Hosted by the Washington State Department of Commerce (WSDC) (http://www.commerce.wa.gov/Pages/default.aspx), this event will be the largest annual gathering of HHS SBIR/STTR federal experts in the country, including representatives from NIH, CDC, FDA and others.
Washington State has a vibrant life science ecosystem making it an ideal location for our conference. The event will take place at Seattle's Destination Waterfront Venue, the Bell Harbor International Conference Center (http://www.bellharbor.com/).
Small businesses at any stage of the commercialization process are welcome to attend – whether you are an SBIR/STTR newcomer or have already reached commercial milestones and seeking outside investors, strategic partners or follow-on funding. We also welcome undergraduate and graduate students, women-owned small businesses and small disadvantaged businesses (https://sbir.nih.gov/about/women-owned). There will be sessions and workshops specifically designed to help you prepare and submit an application to HHS.
Registration expected to open around May.
For more information contact
Kristopher Bough, PhD
Program Director, Division of Basic Neuroscience & Behavioral Research
National Institute on Drug Abuse
6001 Executive Blvd – Rm 4271
Bethesda, MD 20892-9550
Office: 301-443-9800
Email: boughk@mail.nih.gov
----
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
No comments:
Post a Comment